Early detection of familial idiopathic pulmonary fibrosis: lessons for the whole spectrum of interstitial lung diseases
Description: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial lung disease of unknown cause that is usually diagnosed in late adulthood. IPF is of clinical interest because it is associated with a high mortality rate. One of the reasons for poor outcome is the fact that IPF diagnosis is often only made in a more advanced disease stage. Antifibrotic treatment can slow disease progression thereby improving survival. This therapy is equally effective in early compared to more advanced disease. Early identification and diagnosis of IPF will therefore lead to longer disease control and improved survival when adequately treated. Clustering of IPF in families first suggested a genetic component to disease risk. Genome-wide association studies recently identified specific mutations associated with IPF, leading to the definition of familial IPF, which implies that 1 other first-degree relative suffers from a form of pulmonary fibrosis. There is increasing evidence that screening of relatives of familial IPF patients is of high medical importance, as systematic performance of HRCT revealed early IPF in 25% of these asymptomatic relatives. In this project proposal, we aim to pave the way towards early detection of IPF in two ways. Firstly, we will increase our knowledge of familial IPF by performing a thorough comparison with sporadic IPF. Secondly, we will perform a multimodal screening program focusing on relatives of patients with familial IPF.
Funder: Fonds Wetenschappelijk Onderzoek
Funding type: grant
Funder scheme: FWO Strategic Basic Research Grant
Start date: 2020-11-01
End date: 2022-10-31
Investigators: Tinne Goos (lead), Sascha Vermeer (co-lead)
Institutions: Research Foundation - Flanders, FWO
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Funded outputs count: 6
Funder award ID: 1S73921N
OpenAlex ID: G388142008
